A PHASE 3 STUDY OF ACTIVE SURVEILLANCE FOR LOW RISK AND A RANDOMIZED TRIAL OF CARBOPLATIN VS. CISPLATIN FOR STANDARD RISK PEDIATRIC AND ADULT PATIENTS WITH GERM CELL TUMOURS

Registry ID

AGCT1531

Source registry

HEALTH_CANADA

Status

Ongoing

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

CHILDRENS ONCOLOGY GROUP

Start date

2022-02-01

Last update

2017-06-06

Conditions

• GERM CELL TUMOUR

Related clinical trials

• A PHASE II TRIAL EVALUATING CHEMOTHERAPY FOLLOWED BY RESPONSE-BASED REDUCED RADIATION THERAPY FOR PATIENTS WITH CENTRAL NERVOUS SYSTEM GERMINOMAS
• A PHASE 2 TRIAL OF CHEMOTHERAPY FOLLOWED BY RESPONSE-BASED WHOLE VENTRICULAR & SPINAL CANAL IRRADIATION (WVSCI) FOR PATIENTS WITH LOCALIZED NONGERMINOMATOUS CENTRAL NERVOUS SYSTEM GERM CELL TUMOR
• PHASE 3 ACCELERATED BEP TRIAL: A RANDOMISED PHASE 3 TRIAL OF ACCELERATED VERSUS STANDARD BEP CHEMOTHERAPY FOR PATIENTS WITH INTERMEDIATE AND POOR-RISK METASTATIC GERM CELL TUMOURS

View on source registry